Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/28/2011 | EP2368993A2 Method for isolation of soluble polypeptides |
09/28/2011 | EP2368992A2 Method for isolation of soluble polypeptides |
09/28/2011 | EP2368991A2 Method for isolation of soluble polypeptides |
09/28/2011 | EP2368990A1 Method for isolation of soluble polypeptides |
09/28/2011 | EP2368989A1 Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis c virus |
09/28/2011 | EP2368988A1 Modulation of Glucocorticoid Receptor Expression |
09/28/2011 | EP2368987A1 Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same |
09/28/2011 | EP2368986A1 Promoter for introducing gene into lymphocyte or blood cell and application thereof |
09/28/2011 | EP2368985A2 Compositions and methods for generating an immune response |
09/28/2011 | EP2368982A2 Methods and compositions for using zinc finger endonucleases to enhance homologous recombination |
09/28/2011 | EP2368981A2 Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity |
09/28/2011 | EP2368977A1 Mutant luciferase having increased thermostability |
09/28/2011 | EP2368976A1 Mutant luciferase having increased thermostability |
09/28/2011 | EP2368913A2 Glyco-engineered antibodies |
09/28/2011 | EP2368910A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
09/28/2011 | EP2368909A1 GLP-1 analog fusion proteins |
09/28/2011 | EP2368907A2 Anti-Abeta antibodies and their use |
09/28/2011 | EP2368905A2 Process for the control of production of fine chemicals |
09/28/2011 | EP2368904A1 Regulatable growth of filamentous fungi |
09/28/2011 | EP2368903A1 Adenovirus derived helper virus for enhancing recombinant parvovirus production |
09/28/2011 | EP2368902A2 Insulin and IGF-1 receptor agonists and antagonists |
09/28/2011 | EP2368898A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
09/28/2011 | EP2368897A1 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
09/28/2011 | EP2368868A1 Methods for identifying compounds of interest using encoded libraries |
09/28/2011 | EP2368431A1 Immunostimulatory G,U-containing oligoribonucleotides |
09/28/2011 | EP2368430A2 Transgenic fish and uses thereof |
09/28/2011 | EP2367946A1 Genetic material processing and manipulation methods |
09/28/2011 | EP2367945A1 Single recombination system and methods of use |
09/28/2011 | EP2367944A1 Promoters for recombinant viral expression |
09/28/2011 | EP2367943A1 Mammalian expression vector |
09/28/2011 | EP2367942A2 Plant plastid transformation method |
09/28/2011 | EP2367941A2 Plant mitochondria transformation method |
09/28/2011 | EP2367940A2 Mutant penicillin g acylases |
09/28/2011 | EP2367939A1 Methods for diagnosing or treating prostate cancer |
09/28/2011 | EP2367938A1 Genetic cluster of strains of streptococcus thermophilus having unique rheological properties for dairy fermentation |
09/28/2011 | EP2367937A1 Method for the reduction of repetitive sequences in adapter-ligated restriction fragments |
09/28/2011 | EP2367846A1 Hnrnp a3 related peptides and use thereof for diagnosis of rheumatoid arthritis |
09/28/2011 | EP2367844A2 Rsv f vlps and methods of manufacture and use thereof |
09/28/2011 | EP2367843A1 Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin |
09/28/2011 | EP2367841A2 Peptide tag and uses thereof |
09/28/2011 | EP2367418A2 Animal model for osteoarthritis and intervertebral disc disease |
09/28/2011 | EP2367414A1 Transgenic sugar beet event gm rz13 |
09/28/2011 | EP2121918B1 L-threonine overproducing microorganism and method for preparing l-threonine using the same |
09/28/2011 | EP2050332B1 Application of fluorescent protein to horticultural plant |
09/28/2011 | EP1945761B1 Arachnocampa luciferases |
09/28/2011 | EP1937827B1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities |
09/28/2011 | EP1869184B1 Identification of a beta-1,3-n-acetylgalactosaminyltransferase (cgte) from campylobacter jejuni lio87 |
09/28/2011 | EP1854883B1 Assist probes and method of using the same |
09/28/2011 | EP1814987B1 L-amino acid-producing bacterium and a method for producing l-amino acid |
09/28/2011 | EP1687435B1 Insect resistance using inhibition of gene expression |
09/28/2011 | EP1649041B1 Multimeric oxidoreductases |
09/28/2011 | EP1633865B1 New biological entities and the use thereof |
09/28/2011 | EP1583825B1 Metalloprotease proteins |
09/28/2011 | EP1576094B1 Methods of creating modified promoters resulting in varying levels of gene expression |
09/28/2011 | EP1523498B1 Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperazine derivatives |
09/28/2011 | EP1479762B1 Novel dehydrogenase and gene encoding the same |
09/28/2011 | EP1463531B1 Methods for inhibiting ocular processes |
09/28/2011 | EP1442122B1 Manipulation of flavonoid biosynthesis in plants |
09/28/2011 | EP1421191B1 Humanised antibodies specific for both CD45RB and CD45RO |
09/28/2011 | EP1420800B1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
09/28/2011 | EP1403373B1 Saponin-digesting enzymes, genes thereof and soyasapogenol b mass production system |
09/28/2011 | EP1263965B1 Avirulent, immunogenic flavivirus chimeras |
09/28/2011 | EP1161562B9 Deleted sequences in m. bovis bcg/m. bovis or m. tuberculosis, method for detecting mycobacteria using said sequences and vaccines |
09/28/2011 | EP1144613B1 Methods for making proteins containing free cysteine residues |
09/28/2011 | EP0777732B1 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
09/28/2011 | CN1973039B Stabilized proline transporter |
09/28/2011 | CN1970749B Process for preparing prion protein gene-free domestic animals |
09/28/2011 | CN1732259B Method of degrading hardly degradable protein |
09/28/2011 | CN1665842B Human IgM antibody inducing apoptosis in HIV-infected cells and remedy for HIV-infection |
09/28/2011 | CN1630712B Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
09/28/2011 | CN1346369B Method and compositions for the prevention and treatment of anamia |
09/28/2011 | CN102203291A Tbc1d7 as tumor marker and therapeutic target for cancer |
09/28/2011 | CN102203290A Molecular marker for cancer stem cell |
09/28/2011 | CN102203287A Assay methods for increased throughput of samples and/or targets |
09/28/2011 | CN102203285A Methods for haplotype determination by haplodissection |
09/28/2011 | CN102203281A Replica barcode selection assay |
09/28/2011 | CN102203274A Method for producing l-amino acid |
09/28/2011 | CN102203265A Meganuclease recombination system |
09/28/2011 | CN102203264A Insect-derived promoters for foreign proteins expression in insect cells |
09/28/2011 | CN102203263A Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt6 polypeptides and homologs thereof |
09/28/2011 | CN102203262A A method for producing a transgenic cell with increased gamma-aminobutyric acid (gaba) content |
09/28/2011 | CN102203261A Methods and means of increasing the water use efficiency of plants |
09/28/2011 | CN102203260A Compositions and methods of using rna interference for control of nematodes |
09/28/2011 | CN102203259A Nuclear receptor sensor system in transgenic animal |
09/28/2011 | CN102203258A TGF-b antagonist multi-target binding proteins |
09/28/2011 | CN102203257A Genetic incorporation of 3-aminotyrosine into reductases |
09/28/2011 | CN102203256A Heat resistant plants and plant tissues and methods and materials for making and using same |
09/28/2011 | CN102203255A RNA antagonists targeting HSP27 |
09/28/2011 | CN102203254A Sirna compositions and methods for potently inhibiting viral infection |
09/28/2011 | CN102203253A Multiple exon skipping compositions for DMD |
09/28/2011 | CN102203252A Novel immunoadjuvant flagellin-based compounds and use thereof |
09/28/2011 | CN102203251A Methods and kits for extraction of DNA |
09/28/2011 | CN102203250A Syngr4 for target genes of cancer therapy and diagnosis |
09/28/2011 | CN102203249A Method for introducing mutated gene, gene having mutation introduced therein, cassette for introducing mutation, vector for introducing mutation, and knock-in non-human mammal |
09/28/2011 | CN102203248A Tannase, gene encoding same, and process for producing same |
09/28/2011 | CN102203247A Method for detecting functional mold, method for evaluating functional mold-containing product and primer pair |
09/28/2011 | CN102203246A Controllable assembly and disassembly of nanoparticle systems via protein and DNA agents |
09/28/2011 | CN102203244A Process for production of optically active amine derivative |
09/28/2011 | CN102203243A Transgenic plants |
09/28/2011 | CN102203242A Method for the production of adenoviral vectors |